These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. alpha-Glucosidase inhibition in the treatment of diabetes mellitus. Dimitriadis G; Raptis S Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691 [No Abstract] [Full Text] [Related]
3. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes. Welborn TA Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188 [No Abstract] [Full Text] [Related]
4. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus]. Fölsch UR; Lembcke B Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561 [No Abstract] [Full Text] [Related]
5. [Inhibitors of alpha-glucosidase]. Toeller M Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331 [No Abstract] [Full Text] [Related]
6. [New, in Austria registered specialty drugs. Glucobay (acarbose)]. Sturm M Wien Klin Wochenschr; 1992; 104(11):329-36. PubMed ID: 1621396 [No Abstract] [Full Text] [Related]
7. A review of the safety and efficacy of acarbose in diabetes mellitus. Yee HS; Fong NT Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075 [TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus. Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667 [TBL] [Abstract][Full Text] [Related]
9. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle]. Drent ML; van der Veen EA Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796 [No Abstract] [Full Text] [Related]
10. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics. Hayakawa T; Noda A; Kondo T; Okumura N Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176 [No Abstract] [Full Text] [Related]
11. Therapeutic potential of alpha-glucosidase-inhibitors. Fölsch UR Hepatogastroenterology; 1982 Apr; 29(2):47-8. PubMed ID: 7044933 [No Abstract] [Full Text] [Related]
12. [Effect of acarbose on intestinal disaccharidase: review of its therapeutic potential]. Sternberg A; Wagner Y; Fireman Z Harefuah; 1994 May; 126(9):527-9. PubMed ID: 8034269 [No Abstract] [Full Text] [Related]
13. Miglitol and hepatotoxicity in type 2 diabetes mellitus. Carlson RF Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699 [No Abstract] [Full Text] [Related]
14. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study]. García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485 [TBL] [Abstract][Full Text] [Related]
15. [Improvement in diabetes therapy. Interview by Heike E. Nähtke]. Mehnert H Fortschr Med; 1990 Sep; 108(27):72, 75. PubMed ID: 2227754 [No Abstract] [Full Text] [Related]
16. [Acarbose--a new therapeutic principle in diabetes mellitus therapy]. Schöffling K; Hillebrand I Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844 [No Abstract] [Full Text] [Related]
17. Acarbose for diabetes mellitus. Med Lett Drugs Ther; 1996 Feb; 38(967):9-10. PubMed ID: 8559114 [No Abstract] [Full Text] [Related]
19. Clinical experience with acarbose as first line therapy in NIDDM. Fölsch UR Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018 [TBL] [Abstract][Full Text] [Related]
20. [Risk of D-lactate acidosis while receiving acarbose]. Stürmer W; Christl S; Kasper H Dtsch Med Wochenschr; 1995 Mar; 120(9):313. PubMed ID: 7875084 [No Abstract] [Full Text] [Related] [Next] [New Search]